Global K Cells

K Cells Comprehensive Study by Type (Mogamulizumab, Lorvotuzumab Mertansine, Others), Application (Cancer, Cardiovascular Diseases, Others), End-User Industry (Hospitals, Laboratories, Pharmaceuticals, Others) Players and Region - Global Market Outlook to 2026

K Cells Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is K Cells Market Scope?
K Cells are also known as killer cells, it is a type of white blood cell called lymphocyte and a component of the inborn immune system. These cells play an important role in the host-rejection of both tumors and virally infected cells. It contains special proteins such as perforin and proteases known as granzymes. K cells aid to contain viral infections while the adaptive immune response is generating antigen-specific cytotoxic T cells that can clear the infection. Rising prevalence of chronic diseases coupled with rising aging population across globally.

The K Cells market study is being classified by Type (Mogamulizumab, Lorvotuzumab Mertansine and Others), by Application (Cancer, Cardiovascular Diseases and Others) and major geographies with country level break-up.

Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global K Cells market throughout the predicted period.

Takeda Pharmaceutical (Japan), Sorrento Therapeutics Inc. (United States), NantKwest Inc. (United States), Bristol-Myers Squibb (United States) and NKT Therapeutics (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global K Cells market by Type, Application and Region.

On the basis of geography, the market of K Cells has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Adoption of Cellular Therapies as an Emerging Revolutionary Advancement

Market Drivers
  • Rising Ageing Population Coupled With High Prevalence of Chronic Diseases
  • Increasing Awareness About K Cell Therapy Across the Globe

Opportunities
  • Rising, Maturing and Strongly Diversified Clinical Pipeline in both Developed and Developing Countries
  • Growing More and More Laborites and Pharmaceutical Companies in Emerging Nation

Restraints
  • Ethical Issues Related to K Cell Research
  • High Cost of K Cell Analysis Instruments and Reagents

Challenges
  • Lack of Awareness among the People about the Benefit of K Cells
  • Complexities Related To Antibody and Reagent Development
  • Survival of Small Players and New Entrants


Key Target Audience
Laborites, Healthcare centers, Research Firms, Government organization and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
By Application
  • Cancer
  • Cardiovascular Diseases
  • Others
By End-User Industry
  • Hospitals
  • Laboratories
  • Pharmaceuticals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Ageing Population Coupled With High Prevalence of Chronic Diseases
      • 3.2.2. Increasing Awareness About K Cell Therapy Across the Globe
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness among the People about the Benefit of K Cells
      • 3.3.2. Complexities Related To Antibody and Reagent Development
      • 3.3.3. Survival of Small Players and New Entrants
    • 3.4. Market Trends
      • 3.4.1. Adoption of Cellular Therapies as an Emerging Revolutionary Advancement
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global K Cells, by Type, Application, End-User Industry and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global K Cells (Value)
      • 5.2.1. Global K Cells by: Type (Value)
        • 5.2.1.1. Mogamulizumab
        • 5.2.1.2. Lorvotuzumab Mertansine
        • 5.2.1.3. Others
      • 5.2.2. Global K Cells by: Application (Value)
        • 5.2.2.1. Cancer
        • 5.2.2.2. Cardiovascular Diseases
        • 5.2.2.3. Others
      • 5.2.3. Global K Cells by: End-User Industry (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Laboratories
        • 5.2.3.3. Pharmaceuticals
        • 5.2.3.4. Others
      • 5.2.4. Global K Cells Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global K Cells (Volume)
      • 5.3.1. Global K Cells by: Type (Volume)
        • 5.3.1.1. Mogamulizumab
        • 5.3.1.2. Lorvotuzumab Mertansine
        • 5.3.1.3. Others
      • 5.3.2. Global K Cells by: Application (Volume)
        • 5.3.2.1. Cancer
        • 5.3.2.2. Cardiovascular Diseases
        • 5.3.2.3. Others
      • 5.3.3. Global K Cells by: End-User Industry (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Laboratories
        • 5.3.3.3. Pharmaceuticals
        • 5.3.3.4. Others
      • 5.3.4. Global K Cells Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global K Cells (Price)
      • 5.4.1. Global K Cells by: Type (Price)
  • 6. K Cells: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Takeda Pharmaceutical (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sorrento Therapeutics Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. NantKwest Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bristol-Myers Squibb (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. NKT Therapeutics (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
  • 7. Global K Cells Sale, by Type, Application, End-User Industry and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global K Cells (Value)
      • 7.2.1. Global K Cells by: Type (Value)
        • 7.2.1.1. Mogamulizumab
        • 7.2.1.2. Lorvotuzumab Mertansine
        • 7.2.1.3. Others
      • 7.2.2. Global K Cells by: Application (Value)
        • 7.2.2.1. Cancer
        • 7.2.2.2. Cardiovascular Diseases
        • 7.2.2.3. Others
      • 7.2.3. Global K Cells by: End-User Industry (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Laboratories
        • 7.2.3.3. Pharmaceuticals
        • 7.2.3.4. Others
      • 7.2.4. Global K Cells Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global K Cells (Volume)
      • 7.3.1. Global K Cells by: Type (Volume)
        • 7.3.1.1. Mogamulizumab
        • 7.3.1.2. Lorvotuzumab Mertansine
        • 7.3.1.3. Others
      • 7.3.2. Global K Cells by: Application (Volume)
        • 7.3.2.1. Cancer
        • 7.3.2.2. Cardiovascular Diseases
        • 7.3.2.3. Others
      • 7.3.3. Global K Cells by: End-User Industry (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Laboratories
        • 7.3.3.3. Pharmaceuticals
        • 7.3.3.4. Others
      • 7.3.4. Global K Cells Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global K Cells (Price)
      • 7.4.1. Global K Cells by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. K Cells: by Type(USD Million)
  • Table 2. K Cells Mogamulizumab , by Region USD Million (2015-2020)
  • Table 3. K Cells Lorvotuzumab Mertansine , by Region USD Million (2015-2020)
  • Table 4. K Cells Others , by Region USD Million (2015-2020)
  • Table 5. K Cells: by Application(USD Million)
  • Table 6. K Cells Cancer , by Region USD Million (2015-2020)
  • Table 7. K Cells Cardiovascular Diseases , by Region USD Million (2015-2020)
  • Table 8. K Cells Others , by Region USD Million (2015-2020)
  • Table 9. K Cells: by End-User Industry(USD Million)
  • Table 10. K Cells Hospitals , by Region USD Million (2015-2020)
  • Table 11. K Cells Laboratories , by Region USD Million (2015-2020)
  • Table 12. K Cells Pharmaceuticals , by Region USD Million (2015-2020)
  • Table 13. K Cells Others , by Region USD Million (2015-2020)
  • Table 14. South America K Cells, by Country USD Million (2015-2020)
  • Table 15. South America K Cells, by Type USD Million (2015-2020)
  • Table 16. South America K Cells, by Application USD Million (2015-2020)
  • Table 17. South America K Cells, by End-User Industry USD Million (2015-2020)
  • Table 18. Brazil K Cells, by Type USD Million (2015-2020)
  • Table 19. Brazil K Cells, by Application USD Million (2015-2020)
  • Table 20. Brazil K Cells, by End-User Industry USD Million (2015-2020)
  • Table 21. Argentina K Cells, by Type USD Million (2015-2020)
  • Table 22. Argentina K Cells, by Application USD Million (2015-2020)
  • Table 23. Argentina K Cells, by End-User Industry USD Million (2015-2020)
  • Table 24. Rest of South America K Cells, by Type USD Million (2015-2020)
  • Table 25. Rest of South America K Cells, by Application USD Million (2015-2020)
  • Table 26. Rest of South America K Cells, by End-User Industry USD Million (2015-2020)
  • Table 27. Asia Pacific K Cells, by Country USD Million (2015-2020)
  • Table 28. Asia Pacific K Cells, by Type USD Million (2015-2020)
  • Table 29. Asia Pacific K Cells, by Application USD Million (2015-2020)
  • Table 30. Asia Pacific K Cells, by End-User Industry USD Million (2015-2020)
  • Table 31. China K Cells, by Type USD Million (2015-2020)
  • Table 32. China K Cells, by Application USD Million (2015-2020)
  • Table 33. China K Cells, by End-User Industry USD Million (2015-2020)
  • Table 34. Japan K Cells, by Type USD Million (2015-2020)
  • Table 35. Japan K Cells, by Application USD Million (2015-2020)
  • Table 36. Japan K Cells, by End-User Industry USD Million (2015-2020)
  • Table 37. India K Cells, by Type USD Million (2015-2020)
  • Table 38. India K Cells, by Application USD Million (2015-2020)
  • Table 39. India K Cells, by End-User Industry USD Million (2015-2020)
  • Table 40. South Korea K Cells, by Type USD Million (2015-2020)
  • Table 41. South Korea K Cells, by Application USD Million (2015-2020)
  • Table 42. South Korea K Cells, by End-User Industry USD Million (2015-2020)
  • Table 43. Taiwan K Cells, by Type USD Million (2015-2020)
  • Table 44. Taiwan K Cells, by Application USD Million (2015-2020)
  • Table 45. Taiwan K Cells, by End-User Industry USD Million (2015-2020)
  • Table 46. Australia K Cells, by Type USD Million (2015-2020)
  • Table 47. Australia K Cells, by Application USD Million (2015-2020)
  • Table 48. Australia K Cells, by End-User Industry USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific K Cells, by Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific K Cells, by Application USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific K Cells, by End-User Industry USD Million (2015-2020)
  • Table 52. Europe K Cells, by Country USD Million (2015-2020)
  • Table 53. Europe K Cells, by Type USD Million (2015-2020)
  • Table 54. Europe K Cells, by Application USD Million (2015-2020)
  • Table 55. Europe K Cells, by End-User Industry USD Million (2015-2020)
  • Table 56. Germany K Cells, by Type USD Million (2015-2020)
  • Table 57. Germany K Cells, by Application USD Million (2015-2020)
  • Table 58. Germany K Cells, by End-User Industry USD Million (2015-2020)
  • Table 59. France K Cells, by Type USD Million (2015-2020)
  • Table 60. France K Cells, by Application USD Million (2015-2020)
  • Table 61. France K Cells, by End-User Industry USD Million (2015-2020)
  • Table 62. Italy K Cells, by Type USD Million (2015-2020)
  • Table 63. Italy K Cells, by Application USD Million (2015-2020)
  • Table 64. Italy K Cells, by End-User Industry USD Million (2015-2020)
  • Table 65. United Kingdom K Cells, by Type USD Million (2015-2020)
  • Table 66. United Kingdom K Cells, by Application USD Million (2015-2020)
  • Table 67. United Kingdom K Cells, by End-User Industry USD Million (2015-2020)
  • Table 68. Netherlands K Cells, by Type USD Million (2015-2020)
  • Table 69. Netherlands K Cells, by Application USD Million (2015-2020)
  • Table 70. Netherlands K Cells, by End-User Industry USD Million (2015-2020)
  • Table 71. Rest of Europe K Cells, by Type USD Million (2015-2020)
  • Table 72. Rest of Europe K Cells, by Application USD Million (2015-2020)
  • Table 73. Rest of Europe K Cells, by End-User Industry USD Million (2015-2020)
  • Table 74. MEA K Cells, by Country USD Million (2015-2020)
  • Table 75. MEA K Cells, by Type USD Million (2015-2020)
  • Table 76. MEA K Cells, by Application USD Million (2015-2020)
  • Table 77. MEA K Cells, by End-User Industry USD Million (2015-2020)
  • Table 78. Middle East K Cells, by Type USD Million (2015-2020)
  • Table 79. Middle East K Cells, by Application USD Million (2015-2020)
  • Table 80. Middle East K Cells, by End-User Industry USD Million (2015-2020)
  • Table 81. Africa K Cells, by Type USD Million (2015-2020)
  • Table 82. Africa K Cells, by Application USD Million (2015-2020)
  • Table 83. Africa K Cells, by End-User Industry USD Million (2015-2020)
  • Table 84. North America K Cells, by Country USD Million (2015-2020)
  • Table 85. North America K Cells, by Type USD Million (2015-2020)
  • Table 86. North America K Cells, by Application USD Million (2015-2020)
  • Table 87. North America K Cells, by End-User Industry USD Million (2015-2020)
  • Table 88. United States K Cells, by Type USD Million (2015-2020)
  • Table 89. United States K Cells, by Application USD Million (2015-2020)
  • Table 90. United States K Cells, by End-User Industry USD Million (2015-2020)
  • Table 91. Canada K Cells, by Type USD Million (2015-2020)
  • Table 92. Canada K Cells, by Application USD Million (2015-2020)
  • Table 93. Canada K Cells, by End-User Industry USD Million (2015-2020)
  • Table 94. Mexico K Cells, by Type USD Million (2015-2020)
  • Table 95. Mexico K Cells, by Application USD Million (2015-2020)
  • Table 96. Mexico K Cells, by End-User Industry USD Million (2015-2020)
  • Table 97. K Cells Sales: by Type(Unit)
  • Table 98. K Cells Sales Mogamulizumab , by Region Unit (2015-2020)
  • Table 99. K Cells Sales Lorvotuzumab Mertansine , by Region Unit (2015-2020)
  • Table 100. K Cells Sales Others , by Region Unit (2015-2020)
  • Table 101. K Cells Sales: by Application(Unit)
  • Table 102. K Cells Sales Cancer , by Region Unit (2015-2020)
  • Table 103. K Cells Sales Cardiovascular Diseases , by Region Unit (2015-2020)
  • Table 104. K Cells Sales Others , by Region Unit (2015-2020)
  • Table 105. K Cells Sales: by End-User Industry(Unit)
  • Table 106. K Cells Sales Hospitals , by Region Unit (2015-2020)
  • Table 107. K Cells Sales Laboratories , by Region Unit (2015-2020)
  • Table 108. K Cells Sales Pharmaceuticals , by Region Unit (2015-2020)
  • Table 109. K Cells Sales Others , by Region Unit (2015-2020)
  • Table 110. South America K Cells Sales, by Country Unit (2015-2020)
  • Table 111. South America K Cells Sales, by Type Unit (2015-2020)
  • Table 112. South America K Cells Sales, by Application Unit (2015-2020)
  • Table 113. South America K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 114. Brazil K Cells Sales, by Type Unit (2015-2020)
  • Table 115. Brazil K Cells Sales, by Application Unit (2015-2020)
  • Table 116. Brazil K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 117. Argentina K Cells Sales, by Type Unit (2015-2020)
  • Table 118. Argentina K Cells Sales, by Application Unit (2015-2020)
  • Table 119. Argentina K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 120. Rest of South America K Cells Sales, by Type Unit (2015-2020)
  • Table 121. Rest of South America K Cells Sales, by Application Unit (2015-2020)
  • Table 122. Rest of South America K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 123. Asia Pacific K Cells Sales, by Country Unit (2015-2020)
  • Table 124. Asia Pacific K Cells Sales, by Type Unit (2015-2020)
  • Table 125. Asia Pacific K Cells Sales, by Application Unit (2015-2020)
  • Table 126. Asia Pacific K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 127. China K Cells Sales, by Type Unit (2015-2020)
  • Table 128. China K Cells Sales, by Application Unit (2015-2020)
  • Table 129. China K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 130. Japan K Cells Sales, by Type Unit (2015-2020)
  • Table 131. Japan K Cells Sales, by Application Unit (2015-2020)
  • Table 132. Japan K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 133. India K Cells Sales, by Type Unit (2015-2020)
  • Table 134. India K Cells Sales, by Application Unit (2015-2020)
  • Table 135. India K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 136. South Korea K Cells Sales, by Type Unit (2015-2020)
  • Table 137. South Korea K Cells Sales, by Application Unit (2015-2020)
  • Table 138. South Korea K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 139. Taiwan K Cells Sales, by Type Unit (2015-2020)
  • Table 140. Taiwan K Cells Sales, by Application Unit (2015-2020)
  • Table 141. Taiwan K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 142. Australia K Cells Sales, by Type Unit (2015-2020)
  • Table 143. Australia K Cells Sales, by Application Unit (2015-2020)
  • Table 144. Australia K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 145. Rest of Asia-Pacific K Cells Sales, by Type Unit (2015-2020)
  • Table 146. Rest of Asia-Pacific K Cells Sales, by Application Unit (2015-2020)
  • Table 147. Rest of Asia-Pacific K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 148. Europe K Cells Sales, by Country Unit (2015-2020)
  • Table 149. Europe K Cells Sales, by Type Unit (2015-2020)
  • Table 150. Europe K Cells Sales, by Application Unit (2015-2020)
  • Table 151. Europe K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 152. Germany K Cells Sales, by Type Unit (2015-2020)
  • Table 153. Germany K Cells Sales, by Application Unit (2015-2020)
  • Table 154. Germany K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 155. France K Cells Sales, by Type Unit (2015-2020)
  • Table 156. France K Cells Sales, by Application Unit (2015-2020)
  • Table 157. France K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 158. Italy K Cells Sales, by Type Unit (2015-2020)
  • Table 159. Italy K Cells Sales, by Application Unit (2015-2020)
  • Table 160. Italy K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 161. United Kingdom K Cells Sales, by Type Unit (2015-2020)
  • Table 162. United Kingdom K Cells Sales, by Application Unit (2015-2020)
  • Table 163. United Kingdom K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 164. Netherlands K Cells Sales, by Type Unit (2015-2020)
  • Table 165. Netherlands K Cells Sales, by Application Unit (2015-2020)
  • Table 166. Netherlands K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 167. Rest of Europe K Cells Sales, by Type Unit (2015-2020)
  • Table 168. Rest of Europe K Cells Sales, by Application Unit (2015-2020)
  • Table 169. Rest of Europe K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 170. MEA K Cells Sales, by Country Unit (2015-2020)
  • Table 171. MEA K Cells Sales, by Type Unit (2015-2020)
  • Table 172. MEA K Cells Sales, by Application Unit (2015-2020)
  • Table 173. MEA K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 174. Middle East K Cells Sales, by Type Unit (2015-2020)
  • Table 175. Middle East K Cells Sales, by Application Unit (2015-2020)
  • Table 176. Middle East K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 177. Africa K Cells Sales, by Type Unit (2015-2020)
  • Table 178. Africa K Cells Sales, by Application Unit (2015-2020)
  • Table 179. Africa K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 180. North America K Cells Sales, by Country Unit (2015-2020)
  • Table 181. North America K Cells Sales, by Type Unit (2015-2020)
  • Table 182. North America K Cells Sales, by Application Unit (2015-2020)
  • Table 183. North America K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 184. United States K Cells Sales, by Type Unit (2015-2020)
  • Table 185. United States K Cells Sales, by Application Unit (2015-2020)
  • Table 186. United States K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 187. Canada K Cells Sales, by Type Unit (2015-2020)
  • Table 188. Canada K Cells Sales, by Application Unit (2015-2020)
  • Table 189. Canada K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 190. Mexico K Cells Sales, by Type Unit (2015-2020)
  • Table 191. Mexico K Cells Sales, by Application Unit (2015-2020)
  • Table 192. Mexico K Cells Sales, by End-User Industry Unit (2015-2020)
  • Table 193. K Cells: by Type(USD/Units)
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. K Cells: by Type(USD Million)
  • Table 200. K Cells Mogamulizumab , by Region USD Million (2021-2026)
  • Table 201. K Cells Lorvotuzumab Mertansine , by Region USD Million (2021-2026)
  • Table 202. K Cells Others , by Region USD Million (2021-2026)
  • Table 203. K Cells: by Application(USD Million)
  • Table 204. K Cells Cancer , by Region USD Million (2021-2026)
  • Table 205. K Cells Cardiovascular Diseases , by Region USD Million (2021-2026)
  • Table 206. K Cells Others , by Region USD Million (2021-2026)
  • Table 207. K Cells: by End-User Industry(USD Million)
  • Table 208. K Cells Hospitals , by Region USD Million (2021-2026)
  • Table 209. K Cells Laboratories , by Region USD Million (2021-2026)
  • Table 210. K Cells Pharmaceuticals , by Region USD Million (2021-2026)
  • Table 211. K Cells Others , by Region USD Million (2021-2026)
  • Table 212. South America K Cells, by Country USD Million (2021-2026)
  • Table 213. South America K Cells, by Type USD Million (2021-2026)
  • Table 214. South America K Cells, by Application USD Million (2021-2026)
  • Table 215. South America K Cells, by End-User Industry USD Million (2021-2026)
  • Table 216. Brazil K Cells, by Type USD Million (2021-2026)
  • Table 217. Brazil K Cells, by Application USD Million (2021-2026)
  • Table 218. Brazil K Cells, by End-User Industry USD Million (2021-2026)
  • Table 219. Argentina K Cells, by Type USD Million (2021-2026)
  • Table 220. Argentina K Cells, by Application USD Million (2021-2026)
  • Table 221. Argentina K Cells, by End-User Industry USD Million (2021-2026)
  • Table 222. Rest of South America K Cells, by Type USD Million (2021-2026)
  • Table 223. Rest of South America K Cells, by Application USD Million (2021-2026)
  • Table 224. Rest of South America K Cells, by End-User Industry USD Million (2021-2026)
  • Table 225. Asia Pacific K Cells, by Country USD Million (2021-2026)
  • Table 226. Asia Pacific K Cells, by Type USD Million (2021-2026)
  • Table 227. Asia Pacific K Cells, by Application USD Million (2021-2026)
  • Table 228. Asia Pacific K Cells, by End-User Industry USD Million (2021-2026)
  • Table 229. China K Cells, by Type USD Million (2021-2026)
  • Table 230. China K Cells, by Application USD Million (2021-2026)
  • Table 231. China K Cells, by End-User Industry USD Million (2021-2026)
  • Table 232. Japan K Cells, by Type USD Million (2021-2026)
  • Table 233. Japan K Cells, by Application USD Million (2021-2026)
  • Table 234. Japan K Cells, by End-User Industry USD Million (2021-2026)
  • Table 235. India K Cells, by Type USD Million (2021-2026)
  • Table 236. India K Cells, by Application USD Million (2021-2026)
  • Table 237. India K Cells, by End-User Industry USD Million (2021-2026)
  • Table 238. South Korea K Cells, by Type USD Million (2021-2026)
  • Table 239. South Korea K Cells, by Application USD Million (2021-2026)
  • Table 240. South Korea K Cells, by End-User Industry USD Million (2021-2026)
  • Table 241. Taiwan K Cells, by Type USD Million (2021-2026)
  • Table 242. Taiwan K Cells, by Application USD Million (2021-2026)
  • Table 243. Taiwan K Cells, by End-User Industry USD Million (2021-2026)
  • Table 244. Australia K Cells, by Type USD Million (2021-2026)
  • Table 245. Australia K Cells, by Application USD Million (2021-2026)
  • Table 246. Australia K Cells, by End-User Industry USD Million (2021-2026)
  • Table 247. Rest of Asia-Pacific K Cells, by Type USD Million (2021-2026)
  • Table 248. Rest of Asia-Pacific K Cells, by Application USD Million (2021-2026)
  • Table 249. Rest of Asia-Pacific K Cells, by End-User Industry USD Million (2021-2026)
  • Table 250. Europe K Cells, by Country USD Million (2021-2026)
  • Table 251. Europe K Cells, by Type USD Million (2021-2026)
  • Table 252. Europe K Cells, by Application USD Million (2021-2026)
  • Table 253. Europe K Cells, by End-User Industry USD Million (2021-2026)
  • Table 254. Germany K Cells, by Type USD Million (2021-2026)
  • Table 255. Germany K Cells, by Application USD Million (2021-2026)
  • Table 256. Germany K Cells, by End-User Industry USD Million (2021-2026)
  • Table 257. France K Cells, by Type USD Million (2021-2026)
  • Table 258. France K Cells, by Application USD Million (2021-2026)
  • Table 259. France K Cells, by End-User Industry USD Million (2021-2026)
  • Table 260. Italy K Cells, by Type USD Million (2021-2026)
  • Table 261. Italy K Cells, by Application USD Million (2021-2026)
  • Table 262. Italy K Cells, by End-User Industry USD Million (2021-2026)
  • Table 263. United Kingdom K Cells, by Type USD Million (2021-2026)
  • Table 264. United Kingdom K Cells, by Application USD Million (2021-2026)
  • Table 265. United Kingdom K Cells, by End-User Industry USD Million (2021-2026)
  • Table 266. Netherlands K Cells, by Type USD Million (2021-2026)
  • Table 267. Netherlands K Cells, by Application USD Million (2021-2026)
  • Table 268. Netherlands K Cells, by End-User Industry USD Million (2021-2026)
  • Table 269. Rest of Europe K Cells, by Type USD Million (2021-2026)
  • Table 270. Rest of Europe K Cells, by Application USD Million (2021-2026)
  • Table 271. Rest of Europe K Cells, by End-User Industry USD Million (2021-2026)
  • Table 272. MEA K Cells, by Country USD Million (2021-2026)
  • Table 273. MEA K Cells, by Type USD Million (2021-2026)
  • Table 274. MEA K Cells, by Application USD Million (2021-2026)
  • Table 275. MEA K Cells, by End-User Industry USD Million (2021-2026)
  • Table 276. Middle East K Cells, by Type USD Million (2021-2026)
  • Table 277. Middle East K Cells, by Application USD Million (2021-2026)
  • Table 278. Middle East K Cells, by End-User Industry USD Million (2021-2026)
  • Table 279. Africa K Cells, by Type USD Million (2021-2026)
  • Table 280. Africa K Cells, by Application USD Million (2021-2026)
  • Table 281. Africa K Cells, by End-User Industry USD Million (2021-2026)
  • Table 282. North America K Cells, by Country USD Million (2021-2026)
  • Table 283. North America K Cells, by Type USD Million (2021-2026)
  • Table 284. North America K Cells, by Application USD Million (2021-2026)
  • Table 285. North America K Cells, by End-User Industry USD Million (2021-2026)
  • Table 286. United States K Cells, by Type USD Million (2021-2026)
  • Table 287. United States K Cells, by Application USD Million (2021-2026)
  • Table 288. United States K Cells, by End-User Industry USD Million (2021-2026)
  • Table 289. Canada K Cells, by Type USD Million (2021-2026)
  • Table 290. Canada K Cells, by Application USD Million (2021-2026)
  • Table 291. Canada K Cells, by End-User Industry USD Million (2021-2026)
  • Table 292. Mexico K Cells, by Type USD Million (2021-2026)
  • Table 293. Mexico K Cells, by Application USD Million (2021-2026)
  • Table 294. Mexico K Cells, by End-User Industry USD Million (2021-2026)
  • Table 295. K Cells Sales: by Type(Unit)
  • Table 296. K Cells Sales Mogamulizumab , by Region Unit (2021-2026)
  • Table 297. K Cells Sales Lorvotuzumab Mertansine , by Region Unit (2021-2026)
  • Table 298. K Cells Sales Others , by Region Unit (2021-2026)
  • Table 299. K Cells Sales: by Application(Unit)
  • Table 300. K Cells Sales Cancer , by Region Unit (2021-2026)
  • Table 301. K Cells Sales Cardiovascular Diseases , by Region Unit (2021-2026)
  • Table 302. K Cells Sales Others , by Region Unit (2021-2026)
  • Table 303. K Cells Sales: by End-User Industry(Unit)
  • Table 304. K Cells Sales Hospitals , by Region Unit (2021-2026)
  • Table 305. K Cells Sales Laboratories , by Region Unit (2021-2026)
  • Table 306. K Cells Sales Pharmaceuticals , by Region Unit (2021-2026)
  • Table 307. K Cells Sales Others , by Region Unit (2021-2026)
  • Table 308. South America K Cells Sales, by Country Unit (2021-2026)
  • Table 309. South America K Cells Sales, by Type Unit (2021-2026)
  • Table 310. South America K Cells Sales, by Application Unit (2021-2026)
  • Table 311. South America K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 312. Brazil K Cells Sales, by Type Unit (2021-2026)
  • Table 313. Brazil K Cells Sales, by Application Unit (2021-2026)
  • Table 314. Brazil K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 315. Argentina K Cells Sales, by Type Unit (2021-2026)
  • Table 316. Argentina K Cells Sales, by Application Unit (2021-2026)
  • Table 317. Argentina K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 318. Rest of South America K Cells Sales, by Type Unit (2021-2026)
  • Table 319. Rest of South America K Cells Sales, by Application Unit (2021-2026)
  • Table 320. Rest of South America K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 321. Asia Pacific K Cells Sales, by Country Unit (2021-2026)
  • Table 322. Asia Pacific K Cells Sales, by Type Unit (2021-2026)
  • Table 323. Asia Pacific K Cells Sales, by Application Unit (2021-2026)
  • Table 324. Asia Pacific K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 325. China K Cells Sales, by Type Unit (2021-2026)
  • Table 326. China K Cells Sales, by Application Unit (2021-2026)
  • Table 327. China K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 328. Japan K Cells Sales, by Type Unit (2021-2026)
  • Table 329. Japan K Cells Sales, by Application Unit (2021-2026)
  • Table 330. Japan K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 331. India K Cells Sales, by Type Unit (2021-2026)
  • Table 332. India K Cells Sales, by Application Unit (2021-2026)
  • Table 333. India K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 334. South Korea K Cells Sales, by Type Unit (2021-2026)
  • Table 335. South Korea K Cells Sales, by Application Unit (2021-2026)
  • Table 336. South Korea K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 337. Taiwan K Cells Sales, by Type Unit (2021-2026)
  • Table 338. Taiwan K Cells Sales, by Application Unit (2021-2026)
  • Table 339. Taiwan K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 340. Australia K Cells Sales, by Type Unit (2021-2026)
  • Table 341. Australia K Cells Sales, by Application Unit (2021-2026)
  • Table 342. Australia K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 343. Rest of Asia-Pacific K Cells Sales, by Type Unit (2021-2026)
  • Table 344. Rest of Asia-Pacific K Cells Sales, by Application Unit (2021-2026)
  • Table 345. Rest of Asia-Pacific K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 346. Europe K Cells Sales, by Country Unit (2021-2026)
  • Table 347. Europe K Cells Sales, by Type Unit (2021-2026)
  • Table 348. Europe K Cells Sales, by Application Unit (2021-2026)
  • Table 349. Europe K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 350. Germany K Cells Sales, by Type Unit (2021-2026)
  • Table 351. Germany K Cells Sales, by Application Unit (2021-2026)
  • Table 352. Germany K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 353. France K Cells Sales, by Type Unit (2021-2026)
  • Table 354. France K Cells Sales, by Application Unit (2021-2026)
  • Table 355. France K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 356. Italy K Cells Sales, by Type Unit (2021-2026)
  • Table 357. Italy K Cells Sales, by Application Unit (2021-2026)
  • Table 358. Italy K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 359. United Kingdom K Cells Sales, by Type Unit (2021-2026)
  • Table 360. United Kingdom K Cells Sales, by Application Unit (2021-2026)
  • Table 361. United Kingdom K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 362. Netherlands K Cells Sales, by Type Unit (2021-2026)
  • Table 363. Netherlands K Cells Sales, by Application Unit (2021-2026)
  • Table 364. Netherlands K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 365. Rest of Europe K Cells Sales, by Type Unit (2021-2026)
  • Table 366. Rest of Europe K Cells Sales, by Application Unit (2021-2026)
  • Table 367. Rest of Europe K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 368. MEA K Cells Sales, by Country Unit (2021-2026)
  • Table 369. MEA K Cells Sales, by Type Unit (2021-2026)
  • Table 370. MEA K Cells Sales, by Application Unit (2021-2026)
  • Table 371. MEA K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 372. Middle East K Cells Sales, by Type Unit (2021-2026)
  • Table 373. Middle East K Cells Sales, by Application Unit (2021-2026)
  • Table 374. Middle East K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 375. Africa K Cells Sales, by Type Unit (2021-2026)
  • Table 376. Africa K Cells Sales, by Application Unit (2021-2026)
  • Table 377. Africa K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 378. North America K Cells Sales, by Country Unit (2021-2026)
  • Table 379. North America K Cells Sales, by Type Unit (2021-2026)
  • Table 380. North America K Cells Sales, by Application Unit (2021-2026)
  • Table 381. North America K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 382. United States K Cells Sales, by Type Unit (2021-2026)
  • Table 383. United States K Cells Sales, by Application Unit (2021-2026)
  • Table 384. United States K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 385. Canada K Cells Sales, by Type Unit (2021-2026)
  • Table 386. Canada K Cells Sales, by Application Unit (2021-2026)
  • Table 387. Canada K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 388. Mexico K Cells Sales, by Type Unit (2021-2026)
  • Table 389. Mexico K Cells Sales, by Application Unit (2021-2026)
  • Table 390. Mexico K Cells Sales, by End-User Industry Unit (2021-2026)
  • Table 391. K Cells: by Type(USD/Units)
  • Table 392. Research Programs/Design for This Report
  • Table 393. Key Data Information from Secondary Sources
  • Table 394. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global K Cells: by Type USD Million (2015-2020)
  • Figure 5. Global K Cells: by Application USD Million (2015-2020)
  • Figure 6. Global K Cells: by End-User Industry USD Million (2015-2020)
  • Figure 7. South America K Cells Share (%), by Country
  • Figure 8. Asia Pacific K Cells Share (%), by Country
  • Figure 9. Europe K Cells Share (%), by Country
  • Figure 10. MEA K Cells Share (%), by Country
  • Figure 11. North America K Cells Share (%), by Country
  • Figure 12. Global K Cells: by Type Unit (2015-2020)
  • Figure 13. Global K Cells: by Application Unit (2015-2020)
  • Figure 14. Global K Cells: by End-User Industry Unit (2015-2020)
  • Figure 15. South America K Cells Share (%), by Country
  • Figure 16. Asia Pacific K Cells Share (%), by Country
  • Figure 17. Europe K Cells Share (%), by Country
  • Figure 18. MEA K Cells Share (%), by Country
  • Figure 19. North America K Cells Share (%), by Country
  • Figure 20. Global K Cells: by Type USD/Units (2015-2020)
  • Figure 21. Global K Cells share by Players 2020 (%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Takeda Pharmaceutical (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Takeda Pharmaceutical (Japan) Revenue: by Geography 2020
  • Figure 25. Sorrento Therapeutics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Sorrento Therapeutics Inc. (United States) Revenue: by Geography 2020
  • Figure 27. NantKwest Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. NantKwest Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Bristol-Myers Squibb (United States) Revenue, Net Income and Gross profit
  • Figure 30. Bristol-Myers Squibb (United States) Revenue: by Geography 2020
  • Figure 31. NKT Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 32. NKT Therapeutics (United States) Revenue: by Geography 2020
  • Figure 33. Global K Cells: by Type USD Million (2021-2026)
  • Figure 34. Global K Cells: by Application USD Million (2021-2026)
  • Figure 35. Global K Cells: by End-User Industry USD Million (2021-2026)
  • Figure 36. South America K Cells Share (%), by Country
  • Figure 37. Asia Pacific K Cells Share (%), by Country
  • Figure 38. Europe K Cells Share (%), by Country
  • Figure 39. MEA K Cells Share (%), by Country
  • Figure 40. North America K Cells Share (%), by Country
  • Figure 41. Global K Cells: by Type Unit (2021-2026)
  • Figure 42. Global K Cells: by Application Unit (2021-2026)
  • Figure 43. Global K Cells: by End-User Industry Unit (2021-2026)
  • Figure 44. South America K Cells Share (%), by Country
  • Figure 45. Asia Pacific K Cells Share (%), by Country
  • Figure 46. Europe K Cells Share (%), by Country
  • Figure 47. MEA K Cells Share (%), by Country
  • Figure 48. North America K Cells Share (%), by Country
  • Figure 49. Global K Cells: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Takeda Pharmaceutical (Japan)
  • Sorrento Therapeutics Inc. (United States)
  • NantKwest Inc. (United States)
  • Bristol-Myers Squibb (United States)
  • NKT Therapeutics (United States)
Select User Access Type

Key Highlights of Report


Sep 2021 220 Pages 54 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global K Cells Quantitative research analysis
Global K Cells Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global K Cells market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global K Cells market are Takeda Pharmaceutical (Japan), Sorrento Therapeutics Inc. (United States), NantKwest Inc. (United States), Bristol-Myers Squibb (United States) and NKT Therapeutics (United States), to name a few.
In this highly competitive & fast evolving K Cells industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global K Cells Report?

Have a Query? Click Here

Other Related Reports

Fluorescence Microscope Comprehensive Study by Type (Epifluorescence Microscopy, Inverted Fluorescence Microscope), Application (Life Sciences, Material Sciences, Nanotechnology, Other), Components (...
$ 3750
Human Serum Comprehensive Study by Type (Pooled Human Serum, Single Donor Human Serum), Application (Scientific Research, Industrial Production) Players and Region - Global Market Outlook to 2030
$ 3500
Bispecific Antibody Comprehensive Study by Application (Diagnosis of Bacterial Infections, Diagnosis of Viral Infections, BsMAb for Cancer Diagnostic, BsAbs Blocking Signaling Pathways, BsAbs Targeti...
$ 3750
Soybean Trypsin Inhibitor Comprehensive Study by Type (Purity >90%, Purity >95%, Other), Application (Scientific Research, Industrial Production), Form (Powder, Liquid), End User (Pharmaceutical Comp...
$ 3350
Bioprocess Technology Comprehensive Study by Type (Cell Expansion, Cell Culture, Cell Line Development, Flow Cytometry, Virus Infiltration), Application (Specialty Products, Biopharmaceuticals, Envir...
$ 3650
Waste-to-Energy Technologies Comprehensive Study by Type (Thermal, Thermo-Chemical, Mechanical-Thermal, Biochemical), Application (Heat, Fuels, Electricity), Waste Type (Municipal Solid Waste (MSW), ...
$ 3800